Brief: Myriad Genetics Launches Prolaris® + AI
26/05/2026 21:08
BRIEF-Myriad Genetics Launches Prolaris® + AI May 26 (Reuters) - Myriad Genetics Inc MYGN.O:
MYRIAD GENETICS LAUNCHES PROLARIS® + AI, THE FIRST PROSTATE CANCER TEST TO COMBINE GENOMICS AND DIGITAL PATHOLOGY ARTIFICIAL INTELLIGENCE (AI)
Source text: ID:nGNX8rPHQr
Further company coverage: MYGN.O
((Reuters.Briefs@thomsonreuters.com;))